Mable (Neurolytic Healthcare)
Oxford
About Mable (Neurolytic Healthcare)
Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions. The company delivers digitally and genomically-driven medical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.2M
- Funding stage: Seed
- Last round: Pre-Seed (Jul 2022)
- Website: trymable.com
- Phone: 44-739-879-0595
Industries & Categories
Health Care, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/mable-neurolytic-healthcare-70016 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.